A research team analyzed how diabetes mellitus and obesity factor into recurrence and survival after surgery for hepatocellular carcinoma, a type of liver cancer.

Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...

Salivary biomarkers could be the way forward in diagnosing liver fibrosis thanks to a partnership between Griffith University ...

Updated European guidelines for metabolic dysfunction–associated steatotic liver disease stressed a higher risk in people ...

Supported by positive data from Phase 2b FASCINATE-2 trial of denifanstat in patients with MASH Preparations are ongoing to ...

Hepatocellular carcinoma (HCC) represents a significant global health burden as one of the most common malignancies in individuals with chronic liver disease or cirrhosis. This malignancy evolves ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic dysfunction-associated steatotic liver disease ...

Non-alcoholic fatty liver disease (NAFLD), recently reclassified as metabolic ... PPAR agonists, such as pioglitazone and ...

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis ...

In end-stage disease, liver transplantation is the treatment of choice. AIH, autoimmune hepatitis; PBC, primary biliary cirrhosis; PSC, primary sclerosing cholangitis; AIC, autoimmune cholangitis ...

It can be used to treat some people with liver cancer. An important part of the immune system is its ability to keep itself from attacking normal cells in the body. To do this, it uses “checkpoints” – ...